08:56:18 EDT Tue 23 Apr 2024
Enter Symbol
or Name
USA
CA



SEC target Braverman pleads guilty to insider trading

2014-11-25 12:56 ET - Street Wire

Also Street Wire (U-*SEC) U S Securities and Exchange Commission
Also Street Wire (C-YM) YM BioSciences Inc

This item is part of Stockwatch's value added news feed and is only available to Stockwatch subscribers.

Here is a sample of this item:

by Mike Caswell

Dimitry Braverman, a former technician at a California law office, has pleaded guilty to insider trading charges. Prosecutors claimed that he made $305,000 buying shares of seven companies ahead of takeovers after learning about the transactions at work. (All figures are in U.S. dollars.) Among the stocks was former Toronto Stock Exchange listing YM Biosciences Inc., which received a $510-million takeover offer in December, 2012, with Mr. Braverman's employer being an adviser on the transaction.

Mr. Braverman, 41, entered the plea in an appearance before New York Judge Paul Engelmayer on Nov. 13, 2014. The judge allowed him to remain free on a $500,000 appearance bond, which has been in place since his arrest on Sept. 16, 2014. He must return to New York for sentencing on March 6, 2015.

Dimitry Braverman
LINKED IN
Dimitry Braverman

The remainder is available to Stockwatch subscribers.
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

© 2024 Canjex Publishing Ltd. All rights reserved.


Reader Comments - Comments are open to paying subscribers of Stockwatch and unmoderated, although libelous remarks, obscene language and impersonations may be deleted. Opinions expressed do not necessarily reflect the views of Stockwatch.
For information regarding Canadian libel law, please view the University of Ottawa's FAQ regarding Defamation and SLAPPs.


Comments for this item are closed